Emerging Technologies for the Diagnosis of Perihilar Cholangiocarcinoma

被引:56
作者
Rizvi, Sumera [1 ]
Eaton, John [1 ]
Yang, Ju Dong [1 ]
Chandrasekhara, Vinay [1 ]
Gores, Gregory J. [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
cell-free DNA; differentially methylated regions; FISH; PRIMARY SCLEROSING CHOLANGITIS; CONFOCAL LASER ENDOMICROSCOPY; IN-SITU HYBRIDIZATION; CIRCULATING TUMOR-CELLS; FINE-NEEDLE-ASPIRATION; INDETERMINATE BILIARY STRICTURES; ENDOSCOPIC ULTRASOUND; EXTRACELLULAR VESICLES; BRUSH CYTOLOGY; MANAGEMENT;
D O I
10.1055/s-0038-1655775
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The diagnosis of malignant biliary strictures remains problematic, especially in the perihilar region and in primary sclerosing cholangitis (PSC). Conventional cytology obtained during endoscopic retrograde cholangiography (ERC)-guided brushings of biliary strictures is suboptimal due to limited sensitivity, albeit it remains the gold standard with a high specificity. Emerging technologies are being developed and validated to address this pressing unmet patient need. Such technologies include enhanced visualization of the biliary tree by cholangioscopy, intraductal ultrasound, and confocal laser endomicroscopy. Conventional cytology can be aided by employing complementary and advanced cytologic techniques such as fluorescent in situ hybridization (FISH), and this technique should be widely adapted. Interrogation of bile and serum by examining extracellular vesicle number and cargo, and exploiting next-generation sequencing and proteomic technologies, is also being explored. Examination of circulating cell-free deoxyribonucleic acid (cfDNA) for differentially methylated regions is a promising test which is being rigorously validated. The special expertise required for these analyses has to date hampered their validation and adaptation. Herein, we will review these emerging technologies to inform the reader of the progress made and encourage further studies, as well as adaptation of validated approaches.
引用
收藏
页码:160 / 169
页数:10
相关论文
共 78 条
[1]   Intercellular transfer of the oncogenic receptor EGFrvIII by microvesicles derived from tumour cells [J].
Al-Nedawi, Khalid ;
Meehan, Brian ;
Micallef, Johann ;
Lhotak, Vladimir ;
May, Linda ;
Guha, Abhijit ;
Rak, Janusz .
NATURE CELL BIOLOGY, 2008, 10 (05) :619-U24
[2]   Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis [J].
Ali, Ahmad Hassan ;
Tabibian, James H. ;
Nasser-Ghodsi, Navine ;
Lennon, Ryan J. ;
DeLeon, Thomas ;
Borad, Mitesh J. ;
Hilscher, Moira ;
Silveira, Marina G. ;
Carey, Elizabeth J. ;
Lindor, Keith D. .
HEPATOLOGY, 2018, 67 (06) :2338-2351
[3]   Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy [J].
Alix-Panabieres, Catherine ;
Pantel, Klaus .
CANCER DISCOVERY, 2016, 6 (05) :479-491
[4]   The Value of F-18 FDG PET in Patients With Primary Sclerosing Cholangitis and Cholangiocarcinoma Using Visual and Semiquantitative Analysis [J].
Alkhawaldeh, Khaled ;
Faltten, Stephanie ;
Biersack, Hans-J. ;
Ezziddin, Samer .
CLINICAL NUCLEAR MEDICINE, 2011, 36 (10) :879-883
[5]   Four DNA Methylation Biomarkers in Biliary Brush Samples Accurately Identify the Presence of Cholangiocarcinoma [J].
Andresen, Kim ;
Boberg, Kirsten Muri ;
Vedeld, Hege Marie ;
Honne, Hilde ;
Jebsen, Peter ;
Hektoen, Merete ;
Wadsworth, Christopher A. ;
Clausen, Ole Petter ;
Lundin, Knut E. A. ;
Paulsen, Vemund ;
Foss, Aksel ;
Mathisen, Oystein ;
Aabakken, Lars ;
Schrumpf, Erik ;
Lothe, Ragnhild A. ;
Lind, Guro E. .
HEPATOLOGY, 2015, 61 (05) :1651-1659
[6]   Serum Extracellular Vesicles Contain Protein Biomarkers for Primary Sclerosing Cholangitis and Cholangiocarcinoma [J].
Arbelaiz, Ander ;
Azkargorta, Mikel ;
Krawczyk, Marcin ;
Santos-Laso, Alvaro ;
Lapitz, Ainhoa ;
Perugorria, Maria J. ;
Erice, Oihane ;
Gonzalez, Esperanza ;
Jimenez-Aguero, Raul ;
Lacasta, Adelaida ;
Ibarra, Cesar ;
Sanchez-Campos, Alberto ;
Jimeno, Juan P. ;
Lammert, Frank ;
Milkiewicz, Piotr ;
Marzioni, Marco ;
Macias, Rocio I. R. ;
Marin, Jose J. G. ;
Patel, Tushar ;
Gores, Gregory J. ;
Martinez, Ibon ;
Elortza, Felix ;
Falcon-Perez, Juan M. ;
Bujanda, Luis ;
Banales, Jesus M. .
HEPATOLOGY, 2017, 66 (04) :1125-1143
[7]   Long-Term Outcomes of Positive Fluorescence In Situ Hybridization Tests in Primary Sclerosing Cholangitis [J].
Bangarulingam, Sanjay Y. ;
Bjornsson, Einar ;
Enders, Felicity ;
Fritcher, Emily G. Barr ;
Gores, Gregory ;
Halling, Kevin C. ;
Lindor, Keith D. .
HEPATOLOGY, 2010, 51 (01) :174-180
[8]   Primary Sclerosing Cholangitis With Equivocal Cytology [J].
Fritcher, Emily G. Barr ;
Voss, Jesse S. ;
Jenkins, Sarah M. ;
Lingineni, Ravi K. ;
Clayton, Amy C. ;
Roberts, Lewis R. ;
Halling, Kevin C. ;
Talwalkar, Jayant A. ;
Gores, Gregory J. ;
Kipp, Benjamin R. .
CANCER CYTOPATHOLOGY, 2013, 121 (12) :708-717
[9]   Population-Based Epidemiology, Malignancy Risk, and Outcome of Primary Sclerosing Cholangitis [J].
Boonstra, Kirsten ;
Weersma, Rinse K. ;
van Erpecum, Karel J. ;
Rauws, Erik A. ;
Spanier, B. W. Marcel ;
Poen, Alexander C. ;
van Nieuwkerk, Karin M. ;
Drenth, Joost P. ;
Witteman, Ben J. ;
Tuynman, Hans A. ;
Naber, Anton H. ;
Kingma, Paul J. ;
van Buuren, Henk R. ;
van Hoek, Bart ;
Vleggaar, Frank P. ;
van Geloven, Nan ;
Beuers, Ulrich ;
Ponsioen, Cyriel Y. .
HEPATOLOGY, 2013, 58 (06) :2045-2055
[10]   Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia [J].
Boyd, Sonja ;
Tenca, Andrea ;
Jokelainen, Kalle ;
Mustonen, Harri ;
Krogerus, Leena ;
Arola, Johanna ;
Farkkila, Martti A. .
ENDOSCOPY, 2016, 48 (05) :432-439